Continuing our new lecture series in partnership with Y Combinator, we’re excited to bring you Dr. Nikole Times of Siolta Therapeutics,.

Her team is doing fascinating work developing novel microbiome-based therapeutics and diagnostics for the prevention and treatment of chronic inflammatory diseases, starting with atopic diseases.

Our Speaker: Nikole Kimes, PhD

Nikole E. Kimes, PhD is a co-founder and Chief Executive Officer of Siolta Therapeutics, a San Francisco biotech company developing novel microbiome-based therapeutics and diagnostics for the prevention and treatment of chronic inflammatory diseases, starting with atopic diseases.

Dr. Kimes heads a talented team of scientists, blending microbiology, immunology, and bioinformatics expertise to leverage microbiome data for the improvement of patient stratification and development of precision microbial therapeutics. An inventor of Siolta’s technology, her research in co-founder Dr. Susan Lynch’s lab at UCSF provided the foundation from which the translational research program at Siolta Therapeutics has developed.